Suggested Topics within your search.
Suggested Topics within your search.
Antibodies
1
Antibody Formation
1
Article
AstraZeneca COVID-19 vaccine
1
COVID-19
1
COVID-19 Vaccines
1
Humans
1
Immunization, Passive
1
Malawian
1
Prospective Studies
1
RBD
1
RBD antibody
1
SARS-CoV-2
1
SARS-CoV-2 (Germany/FI1103201/2020 (EPI-ISL 463008, D614G))
1
SARS-CoV-2 Delta
1
SARS-CoV-2 antibody
1
SARS-CoV-2 variant 501Y.V2
1
Spike
1
Spike antibody
1
VOC
1
Viral Vaccines
1
adult
1
antibody blood level
1
antibody production
1
antibody response
1
antibody titer
1
cohort analysis
1
coronavirus disease 2019
1
cross reaction
1
drug potency
1
-
1by Afran, L., Ayres, F., Chaponda, M., Chibwana, M.G, Gordon, S.B, Hermanaus, T., Heyderman, R.S, Jambo, K.C, Jassi, C., Jere, K., Kamng’ona, R., Kwatra, G., Madhi, S., Mandolo, J., Mitole, N., Moore, P.L, Motlou, T., Moyo-Gwete, T., Mwandumba, H.C, Mwenechanya, P., Mzindle, N., Mzinza, D., Tembo, G.Subjects: “...AstraZeneca COVID-19 vaccine...”
Published 2022
View Fulltext in Publisher
Article